tolfenamic acid; 13710-19-5; Clotam; 2-[(3-Chloro-2-methylphenyl)amino]benzoic Acid; Tolfedine; N-(3-Chloro-2-methylphenyl)anthranilic acid; GEA 6414; Acido tolfenamico; Acide tolfenamique; Acidum tolfenamicum; 2-((3-Chloro-2-methylphenyl)amino)benzoic acid; 2-(3-Chloro-2-methylanilino)benzoic acid; Benzoic acid, 2-[(3-chloro-2-methylphenyl)amino]-; N-(2-Methyl-3-chlorophenyl)anthranilic acid; N-(3-Chloro-o-tolyl)-anthranilic acid; NSC-757873; Anthranilic acid, N-(3-chloro-o-tolyl)-; DTXSID1045409; CHEBI:32243; N-(3-chloro-o-tolyl)anthranilic; 3G943U18KM; MFCD00133865; NCGC00016705-05; Bifenac; N-(3-Chloro-ortho-tolyl) anthranilic acid; CAS-13710-19-5; Benzoic acid, 2-((3-chloro-2-methylphenyl)amino)-; DTXCID9025409; Tolfine; 2-([3-Chloro-2-methylphenyl]amino)benzoic acid; SR-01000000102; N-(3-Chloro-o-tolyl)anthranilic acid; Tolfenamic; tolfenamic-acid; UNII-3G943U18KM; Acide tolfenamique [INN-French]; Acido tolfenamico [INN-Spanish]; Acidum tolfenamicum [INN-Latin]; Tolfenamic acid [INN:BAN:JAN]; Prestwick_579; EINECS 237-264-3; Clotam (TN); TOLFENAMICACID; BRN 0657821; Spectrum_001263; Tolfenamic acid, NSAID; Prestwick0_000205; Prestwick1_000205; Prestwick2_000205; Prestwick3_000205; Spectrum2_001446; Spectrum3_001762; Spectrum4_000238; Spectrum5_001143; Oprea1_692996; SCHEMBL25190; Tolfenamic acid (JAN/INN); BSPBio_000189; BSPBio_003223; KBioGR_000935; KBioSS_001743; TOLFENAMIC ACID [MI]; MLS000028531; BIDD:GT0343; SPECTRUM1501198; TOLFENAMIC ACID [INN]; TOLFENAMIC ACID [JAN]; SPBio_001311; SPBio_002110; BPBio1_000209; CHEMBL121626; cid_610479; GTPL8769; ZINC2188; TOLFENAMIC ACID [MART.]; BDBM35905; KBio2_001743; KBio2_004311; KBio2_006879; KBio3_002723; YEZNLOUZAIOMLT-UHFFFAOYSA-; TOLFENAMIC ACID [WHO-DD]; HMS1568J11; HMS1921P13; HMS2090D04; HMS2095J11; HMS2230J13; HMS3370A02; HMS3651E06; HMS3712J11; HMS3884M16; Pharmakon1600-01501198; HY-B0335; Tox21_110570; CCG-39189; NSC757873; s1959; TOLFENAMIC ACID [EP IMPURITY]; AKOS012836098; TOLFENAMIC ACID [EP MONOGRAPH]; Tox21_110570_1; 2-(3-Chloro-o-toluidino)benzoic Acid; DB09216; NSC 757873; 2(3-Chloro-2-methylanilino)benzoic acid; NCGC00016705-01; NCGC00016705-02; NCGC00016705-03; NCGC00016705-04; NCGC00016705-06; NCGC00016705-07; NCGC00016705-10; NCGC00022587-03; NCGC00022587-04; NCGC00022587-05; AS-13748; DA-11289; n-(3-chloro-ortho-tolyl)anthranilic acid; SMR000058289; SY052546; SBI-0051687.P002; 2-(3-Chloro-2-methylanilino)benzoic acid #; AB00052244; FT-0652603; SW196753-3; UNM000001237003; 2-(3-chloro-2-methylphenylamino)benzoic acid; 2-((3-Chloro-2-methylphenyl)amino)benzoicacid; D01183; D78227; Q59412; AB00052244-15; AB00052244_16; AB00052244_17; EN300-7416304; Tolfenamic acid 1000 microg/mL in Acetonitrile; A807198; Benzoic acid, 2-(3-chloro-2-methylphenylamino)-; 2-[(3-chloranyl-2-methyl-phenyl)amino]benzoic acid; J-006962; SR-01000000102-2; SR-01000000102-3; Tolfenamic acid, VETRANAL(TM), analytical standard; BRD-K50133271-001-05-4; BRD-K50133271-001-10-4; Tolfenamic acid, European Pharmacopoeia (EP) Reference Standard; Tolfenamic Acid, Pharmaceutical Secondary Standard; Certified Reference Material